These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25323625)

  • 1. The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion.
    Yohn SE; Thompson C; Randall PA; Lee CA; Müller CE; Baqi Y; Correa M; Salamone JD
    Psychopharmacology (Berl); 2015 Apr; 232(7):1313-23. PubMed ID: 25323625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.
    Randall PA; Lee CA; Nunes EJ; Yohn SE; Nowak V; Khan B; Shah P; Pandit S; Vemuri VK; Makriyannis A; Baqi Y; Müller CE; Correa M; Salamone JD
    PLoS One; 2014; 9(6):e99320. PubMed ID: 24937131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.
    Nunes EJ; Randall PA; Hart EE; Freeland C; Yohn SE; Baqi Y; Müller CE; López-Cruz L; Correa M; Salamone JD
    J Neurosci; 2013 Dec; 33(49):19120-30. PubMed ID: 24305809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.
    Yohn SE; Collins SL; Contreras-Mora HM; Errante EL; Rowland MA; Correa M; Salamone JD
    Neuropsychopharmacology; 2016 Feb; 41(3):686-94. PubMed ID: 26105139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure.
    Mott AM; Nunes EJ; Collins LE; Port RG; Sink KS; Hockemeyer J; Müller CE; Salamone JD
    Psychopharmacology (Berl); 2009 May; 204(1):103-12. PubMed ID: 19132351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine depletion shifts behavior from activity based reinforcers to more sedentary ones and adenosine receptor antagonism reverses that shift: Relation to ventral striatum DARPP32 phosphorylation patterns.
    López-Cruz L; San Miguel N; Carratalá-Ros C; Monferrer L; Salamone JD; Correa M
    Neuropharmacology; 2018 Aug; 138():349-359. PubMed ID: 29408363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice.
    Pardo M; Lopez-Cruz L; Valverde O; Ledent C; Baqi Y; Müller CE; Salamone JD; Correa M
    Neuropharmacology; 2012 Apr; 62(5-6):2068-77. PubMed ID: 22261384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
    Podurgiel SJ; Nunes EJ; Yohn SE; Barber J; Thompson A; Milligan M; Lee CA; López-Cruz L; Pardo M; Valverde O; Lendent C; Baqi Y; Müller CE; Correa M; Salamone JD
    Neuroscience; 2013 Oct; 250():507-19. PubMed ID: 23867769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology.
    Rotolo RA; Presby RE; Tracy O; Asar S; Yang JH; Correa M; Murray F; Salamone JD
    Neuropharmacology; 2021 Feb; 183():108325. PubMed ID: 32956676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dopamine depleting agent tetrabenazine alters effort-related decision making as assessed by mouse touchscreen procedures.
    Yang JH; Presby RE; Rotolo RA; Quiles T; Okifo K; Zorda E; Fitch RH; Correa M; Salamone JD
    Psychopharmacology (Berl); 2020 Sep; 237(9):2845-2854. PubMed ID: 32561947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists.
    Yohn SE; Santerre JL; Nunes EJ; Kozak R; Podurgiel SJ; Correa M; Salamone JD
    Pharmacol Biochem Behav; 2015 Aug; 135():217-26. PubMed ID: 26022661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energizing effects of bupropion on effortful behaviors in mice under positive and negative test conditions: modulation of DARPP-32 phosphorylation patterns.
    Carratalá-Ros C; Olivares-García R; Martínez-Verdú A; Arias-Sandoval E; Salamone JD; Correa M
    Psychopharmacology (Berl); 2021 Dec; 238(12):3357-3373. PubMed ID: 34498115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization.
    Yohn SE; Arif Y; Haley A; Tripodi G; Baqi Y; Müller CE; Miguel NS; Correa M; Salamone JD
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3575-86. PubMed ID: 27497935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial reversal of the effort-related motivational effects of tetrabenazine with the MAO-B inhibitor deprenyl (selegiline): Implications for treating motivational dysfunctions.
    Contreras-Mora H; Rowland MA; Yohn SE; Correa M; Salamone JD
    Pharmacol Biochem Behav; 2018 Mar; 166():13-20. PubMed ID: 29309800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task.
    Nunes EJ; Randall PA; Estrada A; Epling B; Hart EE; Lee CA; Baqi Y; Müller CE; Correa M; Salamone JD
    Psychopharmacology (Berl); 2014 Feb; 231(4):727-36. PubMed ID: 24136220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Ingestion and Intraventricular Injection of Curcumin Attenuates the Effort-Related Effects of the VMAT-2 Inhibitor Tetrabenazine: Implications for Motivational Symptoms of Depression.
    Yohn SE; Gorka D; Mistry A; Collins S; Qian E; Correa M; Manchanda A; Bogner RH; Salamone JD
    J Nat Prod; 2017 Oct; 80(10):2839-2844. PubMed ID: 28905625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms.
    Randall PA; Lee CA; Podurgiel SJ; Hart E; Yohn SE; Jones M; Rowland M; López-Cruz L; Correa M; Salamone JD
    Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25575584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effort-related motivational effects of the novel dopamine uptake inhibitor PRX-14040.
    Yohn SE; Gogoj A; Haque A; Lopez-Cruz L; Haley A; Huxley P; Baskin P; Correa M; Salamone JD
    Pharmacol Biochem Behav; 2016 Sep; 148():84-91. PubMed ID: 27296079
    [No Abstract]   [Full Text] [Related]  

  • 19. Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing.
    Farrar AM; Pereira M; Velasco F; Hockemeyer J; Müller CE; Salamone JD
    Psychopharmacology (Berl); 2007 Apr; 191(3):579-86. PubMed ID: 17072593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding.
    Rotolo RA; Kalaba P; Dragacevic V; Presby RE; Neri J; Robertson E; Yang JH; Correa M; Bakulev V; Volkova NN; Pifl C; Lubec G; Salamone JD
    Psychopharmacology (Berl); 2020 Nov; 237(11):3459-3470. PubMed ID: 32770257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.